key: cord-0990691-5h7bgis7
authors: Hoda Siddiqui, Areena; Agarwal, Manoj; Dixit, Nitin
title: Nocardial Pneumonia As An Opportunistic Infection In Covid Treated Patient
date: 2021-08-20
journal: Indian J Tuberc
DOI: 10.1016/j.ijtb.2021.08.022
sha: 9525e9db4a716b3b7c1759f2f486fc361a913fad
doc_id: 990691
cord_uid: 5h7bgis7

nan

We are still evolving with respect to the new virus of SARS CoV2. As the time passes we are coming across new information pertaining to Covid -19. There are various post Covid complications listed in published literatures [1] .

Here we are presenting a case of pulmonary nocardiosis as an opportunistic infection in a covid treated case.

A 47-year-old female came to our hospital with a history of Covid infection in the preceding month. Patient was discharged previously on steroid as a continuation of Covid therapy.

The patient presented with complains of continuous moderate to high grade pyrexia for 15days, troublesome irritant cough, breathing discomfort, generalized weakness for 10 days in the department of emergency. The patient was admitted for further work up.

On admission patient was febrile, conscious and well oriented. Examination revealed HR 84/min, BP 140/70, SpO2 95%, Respiratory 16 rate/minutes, Temperature 99.6 0 F.RT-PCR testing for detection of Covid 19 was negative at the time of admission.

Sputum for Grams stain, culture sensitivity, acid fast bacilli (AFB) stain, gene xpert for TB, blood culture was sent to lab for evaluation.

Blood cultures grew Klebsiella pneumoniae on day 2.Patient was given polymixin ,doxycycline as per sensitivity report. Patient improved by day 6 but again developed cough and fever. virus infection, and long-term steroid therapy. Diagnosis of pulmonary nocardiosis depends on the isolation or demonstration of the organism from respiratory secretions such as sputum or tissue specimens. [2] Treatment guideline have included steroid as therapy for Covid -19. Corticosteroids, though not approved by IDSA, were widely prescribed to prevent the development of ARDS in patients with COVID-19 pneumonia. [3] Corticosteroid has a disadvantage of masking signs of current infection. It can exacerbate the latent infections, including those caused by Amoeba, Candida, Cryptococcus, Mycobacterium, Nocardia, Pneumocystis, Toxoplasma, and fungal infection. [4] There is currently dearth of data regarding complication with steroid therapy in Covid patients. This is first case report where patient after treatment of Covid 19 presented with symptoms of pneumonia.

Extensive work up confirmed nocardial infection. This case shows the importance of considering Nocardial infection as a differential diagnosis in post covid patients presenting with pneumonia. Those patients wherein steroid was added during covid treatment can later present themselves with pulmonary disease or sometimes non resolving pneumonia . In these cases all the opportunistic pathogens must be ruled out before starting any definitive therapy.

J o u r n a l P r e -p r o o f

Long-term effects

Pulmonary nocardiosis in patient with pulmonary tuberculosis in an immunocompetent male: A rare case report

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance. medRxiv